Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 225

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 225
---
 Enfusion’s Directors and Executive Officers in the Transactions.” Conditions to the Transactions The obligation of each of the Buyer Parties and Enfusion to consummate the Transactions is subject to the satisfaction or waiver (where permissible pursuant to applicable law), at or prior to Closing, of each of the following conditions:

| • |     | the obtaining of the Stockholder Approval; |

| • |     | no governmental authority having jurisdiction over the transactions contemplated by the Merger Agreement will                                                                                                                                            
 have issued any order or other action that is in effect (whether temporary, preliminary or permanent) restraining, enjoining or otherwise prohibiting the Closing and no applicable law that makes consummation of the Transactions illegal or otherwise 
 prohibited will be in effect;                                                                                                                                                                                                                            |

| • |     | the effectiveness of this Form S-4 and the absence of any stop order 
 suspending the effectiveness of this Form S-4;                       |

| • |     | the approval for listing for trading on the NYSE of Clearwater Common Stock to be issued pursuant to the Merger 
 Agreement; and                                                                                                  |

| • |     | solely with respect of the Second Merger; the Second Merger Conditions. |

In addition, the obligation of the Buyer Parties to consummate the Transactions is subject to the satisfaction or waiver by Clearwater of each of the following additional conditions:

| • |     | the representations and warranties of Enfusion relating to certain aspects of Enfusion’s corporate existence                                                                                                                                   
 and power, corporate authorization, certain aspects of Enfusion’s capitalization, brokers’ fees and anti-takeover provisions being true and correct in all material respects on the Closing Date as if made on the Closing Date (except to the 
 extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty being true and correct in all material respects only as of such earlier date) after disregarding all   
 “materiality,” “Enfusion Material Adverse Effect” and similar qualifications;                                                                                                                                                                  |

| • |     | the representations and warranties of Enfusion relating to certain aspects of Enfusion’s capitalization                                                                                                                                                  
 being true and correct in all respects on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be 
 true and correct in all respects only as of such specified date), except where the failure to be so true and correct would not reasonably be expected to result in additional cost, expense or liability